Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

BiondVax Pharmaceuticals Ltd (BVXV)

Biological Products, (no Disgnostic Substances)

https://www.biondvax.com

BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/12/2015

Market Cap

4,966,625

Shares Outstanding

1,460,770,000

Weighted SO

3,651,926

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

FWBI --.--%

SLRX --.--%

SLRX --.--%

SABS --.--%

VCNX --.--%

GOVX --.--%

MOLN --.--%

MLYS --.--%

MLYS --.--%

Beta

2.3662

Last Div

0.0000

Range

0.63-11.49

Chg

0.0100

Avg Vol

38939

Mkt Cap

4966625

Exch

NASDAQ

Country

IL

Phone

972 8 930 2529

DCF Diff

0.5027

DCF

1.5727

Div Yield

0.0000

P/S

2.4636

EV Multiple

-1.4798

P/FV

-0.6463

Div Yield %

0.0000

P/E

-2.2880

PEG

-0.0229

Payout

0.0000

Current Ratio

4.1155

Quick Ratio

4.0487

Cash Ratio

3.9756

DSO

24.9851

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-6.2388

Pretax Margin

-3.9070

Net Margin

-0.9964

Eff Tax Rate

0.7636

ROA

-0.1010

ROE

0.4405

ROCE

-0.6984

NI/EBT

0.2550

EBT/EBIT

0.6263

EBIT/Rev

-6.2388

Debt Ratio

1.2370

D/E

-3.4608

LT Debt/Cap

1.4157

Total Debt/Cap

1.4064

Int Coverage

2.1435

CF/Debt

0.4029

Equity Multi

-2.7977

Rec Turnover

14.6087

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.1662

Asset Turnover

0.1013

OCF/Share

2.9341

FCF/Share

2.6757

Cash/Share

2.2210

OCF/Sales

4.9187

FCF/OCF

0.9120

CF Coverage

0.4029

ST Coverage

25.1675

CapEx Coverage

11.3585

Div&CapEx Cov

11.3585

P/BV

-0.6463

P/B

-0.6463

P/S

2.4636

P/E

-2.2880

P/FCF

0.5492

P/OCF

0.4635

P/CF

0.4635

PEG

-0.0229

P/S

2.4636

EV Multiple

-1.4798

P/FV

-0.6463

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation